Streetbeat News

Analyst Ratings

ARVN

Citigroup analyst Yigal Nochomovitz has maintained a 'Buy' rating on Arvinas (NASDAQ:ARVN) but lowered the price target from $72 to $36.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 5:49 pm

BJRI

Citigroup analyst Jon Tower has maintained a Neutral rating on BJ's Restaurants (NASDAQ:BJRI) and lowered the price target from $40 to $29.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 5:47 pm

LBPH

Cantor Fitzgerald analyst Josh Schimmer has assumed Longboard Pharmaceuticals (NASDAQ:LBPH) with an Overweight rating and raised the price target to $35.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 5:46 pm

UPS

A significant bearish stance has been taken on United Parcel Service (NYSE:UPS) as evidenced by unusual options activity. The overall sentiment of these big-money traders is split between 37% bullish and 62% bearish. The whales have been targeting a price range from $100.0 to $180.0 for UPS over the last 3 months. The company's next earnings are expected to be released in 2 days. Analysts from HSBC, Raymond James, Susquehanna, JP Morgan, and Barclays have given their ratings and price targets for UPS.

Portfolio Pulse from Benzinga Insights

October 24, 2023 | 5:46 pm

LRCX

Unusual options activity has been observed for Lam Research (NASDAQ:LRCX), with a large position indicating a bullish stance. The overall sentiment of these big-money traders is split between 72% bullish and 27% bearish. The whales have been targeting a price range from $420.0 to $700.0 for Lam Research over the last 3 months. Analysts from Needham, UBS, B. Riley Securities, and JP Morgan have given positive ratings and high price targets for LRCX.

Portfolio Pulse from Benzinga Insights

October 24, 2023 | 5:45 pm

CMRE

Citigroup analyst Christian Wetherbee maintains a Buy rating on Costamare (NYSE:CMRE) but lowers the price target from $13 to $11.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 5:45 pm

HARP

Citigroup analyst Yigal Nochomovitz maintains a Buy rating on Harpoon Therapeutics (NASDAQ:HARP) but lowers the price target from $33 to $13.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 5:43 pm

PFG

Citigroup analyst Michael Ward maintains a 'Sell' rating on Principal Financial Group (NASDAQ:PFG) and has lowered the price target from $64 to $62.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 5:41 pm

QSR

Citigroup analyst Jon Tower has maintained a Neutral rating on Restaurant Brands Intl (NYSE:QSR) and lowered the price target from $83 to $72.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 5:40 pm

NBIX

Cantor Fitzgerald analyst Charles Duncan has assumed Neurocrine Biosciences (NASDAQ:NBIX) with an Overweight rating.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 5:38 pm